Efficacy of the Rezūm System for lower urinary tract symptoms in patients with benign prostatic hyperplasia: Long term results from a single centre prospective study
In conclusion, the study's findings indicate that patients undergoing Rezūm treatment experience sustained improvements in IPSS, Qmax, PVR and IPSS-related quality of life up to 24 months following the intervention. Anterograde ejaculation remained in 98% of patients after treatment.
Authors
- Francesco Pio Bizzarri (ORCID: https://orcid.org/0000-0003-2119-9023)
- Filippo Marino (ORCID: https://orcid.org/0000-0002-2908-6907)
- Luigi Cosenza
- Emilio Sacco (ORCID: https://orcid.org/0000-0003-4640-8354)
- Angelo Totaro (ORCID: https://orcid.org/0000-0001-6641-6154)
- Filippo Gavi (ORCID: https://orcid.org/0000-0001-9994-4316)
- Pierluigi Russo (ORCID: https://orcid.org/0000-0002-7789-9486)
- Antonio Cretì (ORCID: https://orcid.org/0009-0000-4430-3124)
- Daniele Fettucciari (ORCID: https://orcid.org/0009-0002-1799-3865)
- Domenico Sanesi
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
Publication Details
- Journal
- Urologia Journal
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1177/03915603241297137
- Citations
- 3
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 1.61